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Abstract 
Here we show that retinoic acid (RA) has the ability to alter the transmitter phenotype of cultured sympathetic neurons from newborn rats superior 
cervical ganglia (SCG). In the presence of RA, the level of choline acetyltransferase (ChAT) mRNA was increased, while the level of tyrosine 
hydroxylase (TH) mRNA was reduced in the cultured SCG neurons. Selective PCR amplification of different upstream regions of the ChAT-mRNA 
indicates that RA promotes the transcription of ChAT gene from R and M exons. The RA-induced upregulation of ChAT-mRNA level was 
srgnificantly diminished by the chronic treatment with phorbol ester, suggesting that PKC has an important role in the induction of ChAT-mRNA 
in this system. 
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I. Introduction 
The neurotransmitter phenotype is determined at cer- 
tain stages during neuronal differentiation [l-3] and it 
has been shown that environmental signals play an im- 
portant role in this determination. For example, when 
grown in the presence of nonneuronal cells such as heart 
myocytes and ganglionic nonneuronal cells, adrenergic 
sympathetic neurons dissociated from the superior cervi- 
cal ganglia (KG) of newborn rats can be induced to 
become cholinergic [2]. Leukemia inhibitory factor (LIF) 
purified from the heart cell conditioned medium [4] and 
ciliary neurotrophic factor (CNTF) [5] also have the abil- 
ity to induce cholinergic phenotype. 
Another regulator of neural differentiation which may 
influence the transmitter phenotype is retinoic acid (RA), 
a natural derivative of vitamin A. For example, the local- 
ization of receptors and binding proteins for RA suggest 
its regulatory role in the development of neural structure 
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Abbreviatzons. ChAT. choline acetyltransferase; TH, tyrosine hydrox- 
ylase; RA. retinorc acid; CNTF, ciliary neurotrophic factor; LIE leuke- 
mra inhibitory factor; TPA, phorbol 12,13-myristate acetate; PKC, 
protein kinase C; SCG, superior cervical ganglion; RT-PCR, reverse 
transcriptron-polymerase chain reaction. 
in the central nervous system in vivo [6]. Complementar- 
ily, in vitro studies indicate that RA induces embryonal 
carcinoma cells to differentiate into muscle, glial and 
neuronal (including cholinergic phenotype) cells in a 
concentration dependent manner [7.8]. In a previous 
paper we showed that the exposure of clonal rat pheo- 
chromocytoma cells (PC12) to low concentrations of RA 
increased the activity of choline acetyltransferase 
(ChAT), a marker enzyme of cholinergic neurons, con- 
comitantly with the suppression of the activity of tyro- 
sine hydroxylase (TH), a marker enzyme of adrenergic 
neurons [9]. In the present study, to further investigate 
whether the effects of RA on the clonal cells reflect the 
action of RA on the transmitter choice of the developing 
neuron in vivo, we analyzed the effects of RA on the 
expression of ChAT- and TH-mRNAs in primary cul- 
tured SCG neurons. The results demonstrate that RA 
induces the cholinergic differentiation of SCG neurons 
and strengthen its possible in vivo role in the determina- 
tion of transmitter phenotype. 
2. Materials and methods 
2. I Cell culture 
Adrenergic sympathetic neurons were obtained essentially as de- 
scribed by Saadat et al. [5]. Superior cervical ganglia (SCG) were dis- 
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sected from postnatal day 2 rats, treated with 3 mg/ml collagenase 
(Sigma) in C$‘/MgZ’-free PBS for 30 min and further incubated with 
2 mg/ml trypsin (Difco) for 30 min. Dissociated cells were plated on 
poly-o-lysine/laminin coated 35 mm dishes at a density of 5 ganglia per 
dish. Cells were fed with Ham’s F-12 medium (Sigma) containing 40 ng/ 
ml NGF (Promega), 0.1 mg/ml BSA, antibiotics (50 U/ml penicillin and 
0.1 mg/ml streptomycin), and N2 supplement (5 @g/ml insulin, 
IOO~~rnl transferrin, 20 nM progesterone, 30 nM selenium. 100 PM 
putrexine) [lo]. Culture medium was changed every 3 days. The cells 
were treated with 10 rtM Ara-C (Sigma) for 72 h from the dav followine 
plating to prevent proliferation of nonneuronal cells. All-t&s retinoic 
acid (Sigma; simply abbreviated as RA in the following text) was added 
into the medium from one day after plating of the cells and replenished 
at the time of medium change. The effects of 9-&s RA (generous gift 
from Dr. H. Kagechika and Dr. K. Shudo) and 13-cis RA (Sigma) were 
also examined. These RA isomers were dissolved in ethanol, and the 
volume of ethanol added into the culture medium was controlled so as 
not to exceed 0.2%. 
2 2. RNA preparation and Northern blot analym 
The total RNA was prepared from SCG neurons according to the 
method of Chomzynski and Saccht [I 11 with slight modification. For 
the precipitation of the total RNA from a small number of cells, a high 
molecular weight acrylamide compound (Ethachinmate, Nippon Gene, 
Toyama) was added to the phenol extracts of SCG neurons as carrier. 
Aliquots of the total RNA samples were glyoxylated and electrophore- 
sed bn a 1.5% agarose gel, and then transferred to a nylon membrane 
(Hvbond-N. Ame~ham~. The membranes were fixed bv UV irradia- 
tion, prehybridized and ‘hybridized with “P-1abeled TH>RNA probe 
(transcribed from a rat TH-cDNA plasmid which was a generous gift 
from Dr. H. Fujisawa and Dr. S. Okuno) or ChAT-cRNA probe (tran- 
scribed from a rat ChAT-cDNA plasmid) at 65°C in 50% formamide. 
Radioactivity bound to TH-mRNA and ChAT-mRNA was quantified 
with Bio-Image-Analyzer (FUJI). 
23. RT-PCR 
Although RA-dependent changes were observed on both TH- and 
ChAT-mRNA levels in cultured SCG neurons by Northern blot analy- 
sis, the levels of ChAT-mRNA were too low to be analyzed quantita- 
tively. Therefore, we analyzed the levels of ChAT-mRNA quantita- 
tively by reverse transcription-polymerase chain reaction (RT-PCR). 
Aliquots (0.3 Mug) of the total RNA samples were treated with 0.6 U/p1 
DNaseI (Takara) at 37°C for 15 min. Single strand cDNA was synthe- 
sized with 0.5 PM random hexamer and 0.25 U/p1 AMV-RT (Life 
Sciences Inc.) at 42’C for 45 min. The reaction mixture for PCR 
amplification was prepared using 10 x PCR buffer (Promega). and con- 
tained 0.5 PM each of ChAT primer pair, 0.2 mM each dNTP, 50 nCil@ 
[cr-32P]dCTP and 0.02 U/,& Taq DNA Polymerase (Promega). For the 
amplification of the ChAT coding region, samples were subjected to 
total of 36-39 cycles of PCR according to the followmg scheme: 94°C 
for 50 s, 55°C for 1 min, 72°C for 1 min. After 16 cycles, 0.5 PM each 
of B-actm primer pair was added to the reaction mixture and the PCR 
cycles were further continued. The amplified PCR products were elec- 
trophoresed on a 8% polyacrylamide g l and the radioactivity incorpo- 
rated into ChAT (330 bp) and B-actin (218 bp) cDNA bands was 
quantified with a Bio-Image-Analyzer. The primer sequences used for 
the amplification of the coding regions of ChAT and /?-actin were as 
follows: ChAT CA3, S-CAAGGCCATCTC GCCTCCTCAGCA-X 
ChAT CA8, 5’-CTGCAGCAGCT~AG~TCTCAGA-~ @-actin 
BA5. T-AAGAGAGGCATCCTGACCCT-3’: 8-actin BA3. S-TA- 
CATGGCTGGGGTGTTGAA-3’. 
f 
For the amplification of Y-ends of ChAT-mRNA, the total RNA 
samples were reverse transcribed and subjected to 45 cycles of PCR in 
the absence of a radio-labeled nucleotide according to the following 
scheme: 94°C for 40 s, 65°C for 2 min, 72°C for 3 min. After amplifi- 
cation, the samples were electrophoresed on 2% agarose gel and visual- 
ized by staining with ethidium bromide. The primer sequences used for 
the amplification of S-ends of ChAT-mRNA were as follows: S-Exon- 
specific upstream primers; R, S-T~G~CA~CTGTCGCTGCAA- 
G-3’; N, 5’.TAGTCCCGTCTTTTAGGGTCCTGGCCT-3’; M, S- 
AGTCGAGAGAGGTGTGGCTGGTTT-3’. Common downstream 
primer: REV, 5’-GCTCTTCCTGAACTGCTCTTCACGTACCAY. 
The designations of the upstream primers correspond to those of 5’- 
exons of rat ChAT gene by Kengaku et al, [12] 
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3. Results and discussion 
3.1. Quantitation of ChAT-mRNA expressed in cultured 
SCG neurons 
In order to quantify low levels of ChAT-mRNA ex- 
pression in cultured SCG neurons, we employed quanti- 
tative RT-PCR. When a range of amplification cycles 
between 35 and 40 cycles were tried, logarithmic ampiifi- 
cations of both ChAT-cDNA and /I-actin-cDNA (as an 
endogenous control) were detected with the total RNA 
samples prepared from SCG neurons cultured in the 
absence or presence of lo-I0 M RA for 6 days (Fig. 1). 
Although the levels of ChAT-cDNA amplification in- 
creased by the RA-treatment, the levels oft-actin-cDNA 
amplification were not changed significantly by the RA- 
treatment, indicating that the amplifications of ChAT- 
and j$actin-cDNAs did not interfere with each other 
(Fig. 1, see also Fig. 2C). However, the levels ofj%actin 
expression decreased significantly over the culture period 
concomitantly with the differentiation of SCG neurons. 
as revealed by Northern blot analysis (data not shown). 
Therefore, in the following experiments, the levels of 
ChAT-mRNA expression were first calculated as the ra- 
tios of radioactivity of the ChAT PCR products to that 
of the /I-actin PCR products, then normalized with the 
relative levels of p-actin expression measured by North- 
ern blot analysis and finally expressed as relative values 
per ,ug of total RNA. 
3.2. Effects of RA on ChAT- and TH-mR~A levels 
The treatment of dissociated SCG neurons with RA 
up to 10m6 M for 6 days brought about an elevation of 
the ChAT-mRNA level and a parallel suppression of the 
TH-mRNA level in a concentration dependent manner 
(Fig. 2A,B). Significant effects of RA on the levels of 
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Fig. 2. Effects of RA on ChAT-, TH- and B-actin-mRNA levels in the 
cultured SCG neurons. SCG neurons were cultured for 6 days in the 
presence of indicated concentrations of RA. Then, the total RNA was 
prepared and subjected to quantitation of ChAT-mRNA (A: RT-PCR) 
and TH- and B-actin-mRNA (B and C: Northern blot analysis) levels. 
Points represent he mean and range of two inde~ndent cultures. 
ChAT- and TH-mRNAs of cultured SCG neurons were 
detectable with a RA concentration as low as 10-i’ M. 
The treatment of SCG neurons with 10m6 M RA in- 
creased the ChAT-mRNA level 18-fold but suppressed 
the TH-mRNA level to 25% of that of the control cul- 
ture. In contrast, the level of /I-actin-mRNA was not 
significantly changed by RA-treatment up to lO-‘j M, 
suggesting specific actions of RA on the ChAT and the 
TH gene expressions (Fig. 2C). Cell viability and amount 
of the total RNA extractable from the cultured SCG 
neurons was also not changed significantly by treatment 
with RA up to 10m6 M. However, neither a plateau of 
ChAT-mRNA induction nor complete suppression of 
TH-mRNA by RA was obtained, since RA above 10m6 
M exerted significant toxicity on the culture of SCG 
neurons. 
The effects over time of RA on the expressions of 
ChAT- and TH-mRNAs in the cultured SCG neurons 
were assessed in Fig. 3. In the absence of RA, the TH- 
mRNA level increased 2.5fold between day 1 and day 
13, but the ChAT-mRNA level did not change signifi- 
cantly during this period. When lo-’ M RA was added 
to the culture of SCG neurons at day 1, TH-mRNA level 
began to decrease and reached 50% of the original level 
(20% of that of the control culture) at day 13. On the 
other hand, ChAT mRNA level in the RA-treated cul- 
ture continued to increase over the two-week culture 
period. The induction of ChAT-mRNA and the suppres- 
sion of TH-mRNA were detectable with RA treatment 
at 10e7 M after as little as 3 days. 
RA added at the initial stage of culture (day 1) might 
exert its effect primarily on the nonneuronal cells and 
then subsequently affect the ChAT- and TH-mRNA lev- 
els in neuronal cells, since there existed a number of 
contaminating nonneuronal cells in the initial stage of 
culture. Therefore, we examined the effects of RA added 
on day 7 when virtually all the nonneuronal cells were 
eliminated by Ara-C treatment. As shown in Fig. 3, 
lo-? M RA added on day 7 increased and suppressed the 
ChAT- and TH-mRNA levels, respectively, to extents 
similar to the effects of RA added on day 1, suggesting 
that RA acts directly on neurons to alter their transmit- 
ter phenotype. It is also suggested that SCG neurons do 
not lose their plasticity of transmitter phenotype during 
the culture period of at least 1 week although their 
adrenergic phenotype was further strengthened uring 
this period. 
Our results of the RA action on the cholinergic gene 
regulation of the cultured SCG neurons are consistent 
with our previous observation on PC12 cells [9] and with 
a recent report that RA increases the specific activity of 
ChAT and suppresses the specific activity of TH in the 
cultured SCG neurons [13]. Selective action of RA on 
enhancement of the cholinergic properties has been also 
reported with spinal cord neurons in primary culture 
1141. Considering these findings, our observation sug- 
gests that RA can promote cholinergic differentiation in 
certain in vivo situations during neural development. 
3.3. Mechanism of cholinergic differentiation by RA 
It has been shown that there are at least five different 
mRNA species for ChAT, each differing in their S-non- 
M. Kffbayas~i et al. IFEBS Letters 337 (1994) 259-264 
u 5 10 
Days in Culture 
15 5 10 
Days in Culture 
Fig. 3. Time course of the effects of RA on ChAT- (A) and TH-mRNA (B) levels. RA ( lOa M) was added to SCG neurons at 1 or 7 days after plating. 
Then, neurons were cultured for the indicated periods (closed symbols). ChAT- and TH-mRNA levels in the control culture without RA are shown 
with open symbols. 
coding sequences, in rat spinal cord [12]. The multiple 
CUT-mRNA species are thought to be generated by the 
combination of the use of different promoter regi’ons and 
alternative splicing. We attempted to identify species of 
ChAT-mRNA specifically induced by RA in the cultured 
SCG neurons. Therefore, we synthesized oligonucleotide 
primers specific to different S-noncoding exons and per- 
formed RT-PCR with the total RNA samples from the 
cultured SCG neurons (Fig. 4). In the control culture, 
without the RA-treatment, only the 328 bp band corre- 
sponding to NZtype ChAT-mRNA was detected. In the 
culture of SCG neurons treated with lo-’ M RA for 
6 days, the 262 and 406 bp bands corresponding to R2- 
and M-type mRNA, respectively, were detected. This 
result indicates that the RA-treatment enhances the 
ChAT gene transcription from the two different pro- 
moter regions around R and M exons. Although the 
presence of a responsive element for nuclear retinoid 
receptors is not known, the presence of a number of 
other transcriptional regulatory sites has been reported 
upstream of R exon and downstream of M exon [ 15,161. 
Future study on the analysis of the sequence lements 
around R and M exons mediating the RA-action would 
identify factors involved in the RA-induction of ChAT- 
mRNA. 
In the previous study, we demonstrated that the induc- 
tion of cholinergic phenotype in neuronal cell lines was 
a specific action of RA among retinoid derivatives in- 
cluding retinol and retinal 19). In order to analyze the 
mechanism of the alteration of transmitter phenotype by 
RA, it is important to identify the primary target of RA 
action. It is now generally accepted that RA exerts its 
effects on gene expression through two types of nuclear 
retinoid receptors, i.e. RARs and RXRs. RARs recog- 
nize all-trans RA (RA) and other isomers of RA such as 
9-&s RA and 13-&s RA with similar affinities, while 
RXRs are activated selectively by 9-&r RA [17,18]. Al- 
though the expression of RARs or RXRs in rat SCG is 
not known, temporal expression of RXR/3 in the neural 
crest of chick embryo has been reported [ 191. The 
concentration of RA required to change ChAT- and 
TH-mRNA levels in SCG neurons (Fig. 2) roughly coin- 
cides with that required for activation of nuclear retinoid 
receptors [ 17,181. Therefore, we attempted to elucidate 
the type of nuclear retinoid receptor which regulates the 
transmitter phenotype in the cultured SCG neurons by 
comparing the actions of RA isomers at the concentra- 
tions exerting submaximal effects. Thus, 9-cis RA and 
13-cis RA added at 1 O-‘O M and lo-* M increased ChAT- 
mRNA and suppressed TH-mRNA to extents similar to 
Primer CA318 W3’ N/3’ M/3’ ---- 
RA(iOn~) - + - + - + - + 
Fig. 4. PCR amplification of 5’-regions of ChAT-mRNA from the 
cultured SCG neurons. KG neurons were cultured in the absence or 
presence of IO‘* M RA for 6 days. Then, the total RNA was prepared 
and S-regions of ChAT-mRNA were amplified by RT-PCR using the 
primer pairs each consisting of a common 3’-primer (REV) and a 
different S-primer ~~esponding to S’exons (R, N, and M) of rat 
ChAT gene. Coding region of ChAT-mRNA (330 bp) was aiso amph- 
fied with CA3 and CA8 primers. After separation on a 2% agarose gel, 
the amplification products were stained with ethidium bromide. Ex- 
pected positions of various types of ChAT-mRNA species are indicated 
on the right side of the gel; M (406 bp). N2 (328 bp), R2 (262 bp). 
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Fig. 5. Effects of chronic treatment of the SCG neurons with phorbol esters on the ChAT- and TH-mRNA levels. SCG neurons were cultured for 
6 days in the presence of the indicated combinations of lo-’ M RA, 5 nM TPA and 5 nM 4a-TPA. Neurons were then harvested and subjected to 
the quantitation of ChAT- (A) and TH-mRNA (B) levels. Data represent he mean and the range of the two independent cultures. 
those affected by all-truns RA (RA) (data not shown). 
This result suggests that the dominant involvement of 
RXRs over RARs in controlling transmitter phenotype 
in SCG neurons by RA is unlikely and rather suggests 
that RARs take part in the regulation of the transmitter 
related genes in this system. For further identification of 
the responsible receptor type in the action of RA, one has 
to examine the expression of a particular type of RARs 
in SCG neurons. Detection of the expression of RARs/ 
RXRs in SCG in any particular developmental stage 
would also establish the in vivo role of RA in the devel- 
opment of sympathetic neurons. 
Besides RA, several peptide factors such as CNTF and 
LIF are known to induce cholinergic differentiation in 
the cultured SCG neurons [4,5]. Although RA. which 
binds to the nuclear retinoid receptor, and CNTF/LIF, 
which binds to specific receptors associated with com- 
mon receptor subunit, gpl30, on the plasma membrane, 
seem to have different upstream mechanisms of their 
actions, there still remains the possibility that they also 
share a common downstream mechanism of inducing 
cholinergic properties. Recently it was reported that the 
induction of cholinergic properties in SCG neurons by 
CNTF and LIF is mediated by the activation of protein 
kinase C (PKC) [20]. Therefore, we also examined the 
effect of chronic treatment of SCG neurons with phorbol 
12,13-myristate acetate (TPA), which was shown to de- 
plete PKC activity in the cultured SCG neurons [20], on 
the ChAT- and TH-mRNA levels affected by RA. As 
shown in Fig. 5A, The treatment of SCG neurons with 
5 nM TPA alone for 6 days did not change the ChAT- 
mRNA level significantly. But, TPA added in combina- 
tion with 10e7 M RA inhibited the RA-induced ChAT- 
mRNA level, while 4a-TPA, which does not act on PKC, 
was less effective than TPA in suppressing the RA- 
induced ChAT-mRNA level. These results suggest that 
the induction of ChAT-mRNA in the cultured SCG neu- 
rons is also mediated by a PKC-dependent process and 
is consistent with our previous result that H-7, an inhib- 
itor of PKC, abolished the RA-induced ChAT activity 
in PC12 cells [21]. However, the chronic treatment with 
TPA alone slightly suppressed the TH-mRNA level. The 
combination of TPA and RA suppressed the TH-mRNA 
level in an additive manner suggesting that the activation 
of PKC is not necessary for TH-mRNA suppression by 
RA. 
In the present study, we showed that RA regulates the 
expressions of ChAT and TH genes in a mutually exclu- 
sive manner. Direct activation of transcription of the 
ChAT gene is less likely, since a typical retinoid receptor 
responsive lement has not been found on the identified 
promoter/enhancer regions of ChAT gene. It is rather 
tempting to assume that, in response to RA, the nuclear 
retinoid receptor activates the expression of its target 
gene whose product functions as a transcription factor 
for ChAT gene. Although activation of a nuclear reti- 
noid receptor by PKC is rather unlikely, it is plausible 
that the putative target gene of this receptor is activated 
by PKC. Such a putative target gene of RA action may 
also serve as the target gene for the actions of CNTF and 
LIF [20] and thus, may have key roles in cholinergic 
differentiation. 
On the other hand, recent observations have indicated 
that RA downregulates the expression of target genes by 
blocking transcriptional activation at an AP-1 site on 
their promote [22-241. These observations raise a possi- 
bility that a RA-retinoid receptor complex blocks the 
activity of the AP-1 site on the TH-promoter which has 
been shown to be involved in the PKC-mediated activa- 
tion of TH gene expression [25]. Direct binding of a 
RA-retinoid receptor complex to an AP-1 site is rather 
controversial [22-241. Alternatively, a RA-retinoid re- 
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ceptor complex would activate the transcription of the 
target gene whose product functions as an negative regu- 
lator of TH gene transcription. It is tempting to speculate 
that a positive transcription factor for ChAT gene in- 
duced by RA also functions as the negative regulator for 
TH gene, which would explain the mutually exclusive 
expression of these two genes in neuronal cells. Our cur- 
rent efforts are concentrated on identifying such a target 
molecule of the RA-action in the cholinergic differentia- 
tion of neuronal cells [26]. 
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